HEXABRIX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hexabrix, and what generic alternatives are available?
Hexabrix is a drug marketed by Guerbet and is included in one NDA.
The generic ingredient in HEXABRIX is ioxaglate meglumine; ioxaglate sodium. Additional details are available on the ioxaglate meglumine; ioxaglate sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HEXABRIX?
- What are the global sales for HEXABRIX?
- What is Average Wholesale Price for HEXABRIX?
Summary for HEXABRIX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 21 |
Clinical Trials: | 2 |
Patent Applications: | 100 |
Formulation / Manufacturing: | see details |
DailyMed Link: | HEXABRIX at DailyMed |
![HEXABRIX drug patent expirations Drug patent expirations by year for HEXABRIX](/p/graph/s/t/HEXABRIX-patent-expirations.png)
Recent Clinical Trials for HEXABRIX
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Guerbet | Phase 4 |
NYU Langone Health | Phase 4 |
New York University School of Medicine | Phase 4 |
US Patents and Regulatory Information for HEXABRIX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HEXABRIX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | ⤷ Sign Up | ⤷ Sign Up |
Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for HEXABRIX
See the table below for patents covering HEXABRIX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | S514133 | ⤷ Sign Up | |
Argentina | 207465 | PROCEDIMIENTO DE PREPARACION DE DERIVADOS DE ACIDO TRIIODOI2,4,6-(TRIIODO-2,4,6-BENZOIL)-AMINO-ALCANOILAMINOBENZOICO DE ACIDO TRIIODO-2,4,6-(TRIIODO-2,4,6-(TRIIODO-2,4,6-BENZOIL)-AMINOALCANOILAMINOBENZOIL)-AMINO-ALCANOIL-AMINOBENZOICO Y DE ACIDO TRIIODO-2,4,6-BIS((TRIIODO-2,4,6-FENIL)-CARBAMOIL-METIL)-AMINOALCANOIL-AMINOBENZOICO | ⤷ Sign Up |
Spain | 437996 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |